Text Size

Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems

This study has been completed.
Sponsor:
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00366665
First received: August 17, 2006
Last updated: NA
Last verified: May 2005
History: No changes posted
  Purpose

To compare the efficiency of the Infiniti vision system and the Series 20000 Legacy System phacoemulsification units during routine cataract extraction.


Condition Intervention
Cataract Extraction
 Device: Legacy 20000
Device: Infinit system

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Comparison of the Infiniti Vision and the Series 20000 Legacy Systems

Resource links provided by NLM:

MedlinePlus related topics: Cataract
U.S. FDA Resources

Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Ultrasound time
  • Amount of fluid used
  • Post operative visual acuity.

Estimated Enrollment: 30
Study Start Date: March 2005
Estimated Study Completion Date: May 2005
  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cataract
  • Eligible for cataract extraction with primary implantation of a posterior chamber IOL
  • 2 to 3+ cataract density

Exclusion Criteria:

  • Preoperative ocular pathology that can affect visual acuity
  • Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.
  • Previous intraocular or corneal surgery.
  • Other ocular surgery at the time of the cataract extraction.
  • Surgical Exclusion Criteria:
  • Significant intraoperative intraocular bleeding
  • Detached Descemet’s membrane
  • Implantation of the intraocular lens in the anterior chamber or sulcus
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00366665

Sponsors and Collaborators
Medical University of South Carolina
Investigators
Principal Investigator: Kerry D. Solomon, MD Medical University of South Carolina
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00366665     History of Changes
Other Study ID Numbers: MRC-05-002
Study First Received: August 17, 2006
Last Updated: August 17, 2006
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Cataract
Lens Diseases
Eye Diseases

ClinicalTrials.gov processed this record on May 21, 2013